Of Myc and Mnt

Journal of Cell Science

Volumn 119, Issue 2, 2006, Pages 208-216

  Hooker, C William ^a   Hurlin, Peter J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cancer; Cell cycle; Mad; Max; Mnt; Mxd; Myc

Indexed keywords

GENE PRODUCT; MICRORNA; MYC PROTEIN; PROTEIN MNT; RIBOSOME RNA; TRANSFER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CORRELATION ANALYSIS; DNA BINDING; DOWN REGULATION; EMBRYO DEVELOPMENT; FIBROBLAST; GENETIC ANALYSIS; GENETIC CODE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RNA ANALYSIS; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MACROMOLECULAR SUBSTANCES; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS;

EID: 32244448365     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02815     Document Type: Article

References (111)

1. Adhikary, S. and Eilers, M. (2005). Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol. 6, 635-645.
2. Alland, L., Muhle, R., Hou, H., Jr, Potes, J., Chin, L., Schreiber-Agus, N. and DePinho, R. A. (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55.
3. Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I. and Land, H. (1992). Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423-426.
4. Amin, C., Wagner, A. J. and Hay, N. (1993). Sequence-specific transcriptional activation by myc and repression by max. Mol. Cell. Biol. 13, 383-390.
5. Arabi, A., Wu, S., Ridderstrale, K., Bierhoff, H., Shiue, C., Fatyol, K., Fahlen, S., Hydbring, P., Soderberg, O., Grummt, I. et al. (2005). c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol. 7, 303-310.
6. Askew, D. S., Ashman, R. A., Simmons, B. C. and Cleveland, J. L. (1991). Constitutive c-Myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
7. Ayer, D. E. and Eisenman, R. N. (1993). A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7, 2110-2119.
8. Ayer, D. E., Kretzner, L. and Eisenman, R. N. (1993). Mad: a heterodimeric partner for max that antagonizes Myc transcriptional activity. Cell 72, 211-222.
9. Ayer, D. E., Lawrence, Q. A. and Eisenman, R. N. (1995). Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776.
10. Beier, R., Burgin, A., Kiermaier, A., Fero, M., Karsunky, H., Saffrich, R., Moroy, T., Ansorge, W., Roberts, J. and Eilers, M. (2000). Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J. 19, 5813-5823.
11. Berberich, S. J. and Cole, M. D. (1992). Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6, 166-176.
12. Berns, K., Hijmans, E. M., Koh, E., Daley, G. Q. and Bernards, R. (2000). A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19, 3330-3334.
13. Bettess, M. D., Dubois, N., Murphy, M. J., Dubey, C., Roger, C., Robine, S. and Trumpp, A. (2005). C-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol. Cell. Biol. 25, 7868-7878.
14. Billin, A. N., Eilers, A. L., Queva, C. and Ayer, D. E. (1999). Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J. Biol. Chem. 274, 36344-36350.
15. Blackwell, T. K., Huang, J., Ma, A., Kretzner, L., Alt, F. W., Eisenman, R. N. and Weintraub, H. (1993). Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13, 5216-5224.
16. Blackwood, E. M. and Eisenman, R. N. (1991). Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217.
17. Blackwood, E. M., Luscher, B. and Eisenman, R. N. (1992). Myc and Max associate in vivo. Genes Dev. 6, 71-80.
18. Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J. and Eilers, M. (1999). Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321-5333.
19. Bouchard, C., Dittrich, O., Kiermaier, A., Dohmann, K., Menkel, A., Eilers, M. and Luscher, B. (2001). Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15, 2042-2047.
20. Bouchard, C., Marquardt, J., Bras, A., Medema, R. H. and Eilers, M. (2004). Myc-induced proliferation and transformation require akt-mediated phosphorylation of foxO proteins. EMBO J. 23, 2830-2840.
21. Bourbon, H. M., Gonzy-Treboul, G., Peronnet, F., Alin, M. F., Ardourel, C., Benassayag, C., Cribbs, D., Deutsch, J., Ferrer, P., Haenlin, M. et al. (2002). A P-insertion screen identifying novel X-linked essential genes in drosophila. Mech. Dev. 110, 71-83.
22. Cawley, S., Bekiranov, S., Ng, H. H., Kapranov, P., Sekinger, E. A., Kampa, D., Piccolboni, A., Sementchenko, V., Cheng, J., Williams, A. J. et al. (2004). Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509.
23. Cleveland, J. L., Huleihel, M., Bressler, P., Siebenlist, U., Akiyama, L., Eisenman, R. N. and Rapp, U. R. (1988). Negative regulation of c-Myc transcription involves Myc family proteins. Oncogene Res. 3, 357-375.
24. de Alboran, I. M., O'Hagan, R. C., Gartner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R. A. and Alt, F. W. (2001). Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14, 45-55.
25. Eilers, M., Schirm, S. and Bishop, J. M. (1991). The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10, 133-141.
26. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
27. Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A. and Amati, B. (2003). Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129.
28. Foley, K. P., McArthur, G. A., Queva, C., Hurlin, P. J., Soriano, P. and Eisenman, R. N. (1998). Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17, 774-785.
29. Fox, E. J. and Wright, S. C. (2001). S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. Biochem. J. 359, 361-367.
30. Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. M., Livingston, D. M. and Amati, B. (2003). MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4, 575-580.
31. Gallant, P., Shiio, Y., Cheng, P. F., Parkhurst, S. M. and Eisenman, R. N. (1996). Myc and Max homologs in Drosophila. Science 274, 1523-1527.
32. Gomez-Roman, N., Grandori, C., Eisenman, R. N. and White, R. J. (2003). Direct activation of RNA polymerase III transcription by c-Myc. Nature 421, 290-294.
33. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699.
34. Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N. and White, R. J. (2005). c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7, 311-318.
35. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N. and Edgar, B. A. (2005). Myc-dependent regulation of ribosomal RNA Synthesis during Drosophila development. Nat. Cell Biol. 7, 295-302.
36. Grignani, F., Lombardi, L., Inghirami, G., Sternas, L., Cechova, K. and Dalla-Favera, R. (1990). Negative autoregulation of c-Myc gene expression is inactivated in transformed cells. EMBO J. 9, 3913-3922.
37. Hann, S. R., Thompson, C. B. and Eisenman, R. N. (1985). c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314, 366-369.
38. Harrington, E. A., Bennett, M. R., Fanidi, A. and Evan, G. I. (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13, 3286-3295.
39. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L. and Ayer, D. E. (1997). Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347.
40. Hatton, K. S., Mahon, K., Chin, L., Chiu, F. C., Lee, H. W., Peng, D., Morgenbesser, S. D., Horner, J. and DePinho, R. A. (1996). Expression and activity of L-Myc in normal mouse development. Mol. Cell. Biol. 16, 1794-1804.
41. Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P. and Lowe, S. W. (2005). Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436, 807-811.
42. Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W. and Kohlhuber, F. et al. (2000). Identification of CDK4 as a Target of c-MYC. Proc. Natl. Acad. Sci. USA 97, 2229-2234.
43. Herold, S., Wanzel, M., Beuger, V., Frohme, C., Beul, D., Hillukkala, T., Syvaoja, J., Saluz, H. P., Haenel, F. and Eilers, M. (2002). Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell 10, 509-521.
44. Hurlin, P. J., Foley, K. P., Ayer, D. E., Eisenman, R. N., Hanahan, D. and Arbeit, J. M. (1995a). Regulation of Myc and Mad during epidermal differentiation and HPVassociated tumorigenesis. Oncogene 11, 2487-2501.
45. Hurlin, P. J., Queva, C., Koskinen, P. J., Steingrimsson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A. and Eisenman, R. N. (1995b). Mad3 and Mad4: novel Max interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14, 5646-5659.
46. Hurlin, P. J., Queva, C. and Eisenman, R. N. (1997a). Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58.
47. Hurlin, P. J., Queva, C. and Eisenman, R. N. (1997b). Mnt: a novel Max-interacting protein and Myc antagonist. Curr. Top. Microbiol. Immunol. 224, 115-121.
48. Hurlin, P. J., Steingrimsson, E., Copeland, N. G., Jenkins, N. A. and Eisenman, R. N. (1999). Mga, a dual-specificity transcription factor that interacts with max and contains a T-domain DNA-binding motif. EMBO J. 18, 7019-7028.
49. Hurlin, P. J., Zhou, Z. Q., Toyo-oka, K., Ota, S., Walker, W. L., Hirotsune, S. and Wynshaw-Boris, A. (2003). Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 22, 4584-4596.
50. Iritani, B. M. and Eisenman, R. N. (1999). c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA 96, 13180-13185.
51. Iritani, B. M., Delrow, J., Grandori, C., Gomez, I., Klacking, M., Carlos, L. S. and Eisenman, R. N. (2002). Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J. 21, 4820-4830.
52. James, L. and Eisenman, R. N. (2002). Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc. Natl. Acad. Sci. USA 99, 10429-10434.
53. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. and Gallant, P. (1999). Drosophila Myc regulates cellular growth during development. Cell 98, 779-790.
54. Kato, G. J., Lee, W. M., Chen, L. L. and Dang, C. V. (1992). Max: functional domains and interaction with c-Myc. Genes Dev. 6, 81-92.
55. Kelly, K., Cochran, B. H., Stiles, C. D. and Leder, P. (1983). Cell-specific regulation of the c-Myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35, 603-610.
56. Knoepfler, P. S., Cheng, P. F. and Eisenman, R. N. (2002). N-Myc is Essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712.
57. Kretzner, L., Blackwood, E. M. and Eisenman, R. N. (1992). Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426-429.
58. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E. and Eisenman, R. N. (1997). Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356.
59. Lindeman, G. J., Harris, A. W., Bath, M. L., Eisenman, R. N. and Adams, J. M. (1995). Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice. Oncogene 10, 1013-1017.
60. Littlewood, T. D., Amati, B., Land, H. and Evan, G. I. (1992). Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7, 1783-1792.
61. Loo, L. W., Secombe, J., Little, J. T., Carlos, L. S., Yost, C., Cheng, P. F., Flynn, E. M., Edgar, B. A. and Eisenman, R. N. (2005). The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster. Mol. Cell. Biol. 25, 7078-7091.
62. Lowe, S. W., Cepero, E. and Evan, G. (2004). Intrinsic tumour suppression. Nature 432, 307-315.
63. Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A. and Alt, F. W. (2000). N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399.
64. Marcotte, R., Qian, J. F., Chen, J. and Wang, E. (2003). hMad4, c-Myc endogenous inhibitor, induces a replicative senescence-like state when overexpressed in human fibroblasts. J. Cell Biochem. 89, 576-588.
65. Mateyak, M. K., Obaya, A. J., Adachi, S. and Sedivy, J. M. (1997). Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8, 1039-1048.
66. McMahon, S. B., Wood, M. A. and Cole, M. D. (2000). The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20, 556-562.
67. Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H. et al. (1997). Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J. 16, 2892-2906.
68. Meroni, G., Cairo, S., Merla, G., Messali, S., Brent, R., Ballabio, A. and Reymond, A. (2000). Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? Oncogene 19, 3266-3277.
69. Nikiforov, M. A., Kotenko, I., Petrenko, O., Beavis, A., Valenick, L., Lemischka, I. and Cole, M. D. (2000). Complementation of Myc-dependent cell proliferation by cDNA expression library screening. Oncogene 19, 4828-4831.
70. Nilsson, J. A. and Cleveland, J. L. (2003). Myc pathways provoking cell suicide and cancer. Oncogene 22, 9007-9021.
71. Nilsson, J. A., Maclean, K. H., Keller, U. B., Pendeville, H., Baudino, T. A. and Cleveland, J. L. (2004). Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol. Cell. Biol. 24, 1560-1569.
72. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. and Mendell, J. T. (2005). C-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843.
73. O'Hagan, R. C., Schreiber-Agus, N., Chen, K., David, G., Engelman, J. A., Schwab, R., Alland, L., Thomson, C., Ronning, D. R. and Sacchettini, J. C. et al. (2000). Gene-target recognition among members of the Myc superfamily and implications for oncogenesis. Nat. Genet. 24, 113-119.
74. Orian, A., van Steensel, B., Delrow, J., Bussemaker, H. J., Li, L., Sawado, T., Williams, E., Loo, L. W., Cowley, S. M., Yost, C. et al. (2003). Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114.
75. Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C. and McMahon, S. B. (2004). Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4, 562-568.
76. Pelengaris, S., Khan, M. and Evan, G. (2002). c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2, 764-776.
77. Peukert, K., Staller, P., Schneider, A., Carmichael, G., Hanel, F. and Eilers, M. (1997). An alternative pathway for gene regulation by Myc. EMBO J. 16, 5672-5686.
78. Poortinga, G., Hannan, K. M., Snelling, H., Walkley, C. R., Jenkins, A., Sharkey, K., Wall, M., Brandenburger, Y., Palatsides, M., Pearson, R. B. et al. (2004). MAD1 and c-MYC regulate ubf and rdna transcription during granulocyte differentiation. EMBO J. 23, 3325-3335.
79. Popov, N., Wahlstrom, T., Hurlin, P. J. and Henriksson, M. (2005). Mnt transcriptional repressor is functionally regulated during cell cycle progression. Oncogene doi: 10.1038/sj.onc.1208961
80. Prendergast, G. C., Lawe, D. and Ziff, E. B. (1991). Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65, 395-407.
81. Pulverer, B., Sommer, A., McArthur, G. A., Eisenman, R. N. and Luscher, B. (2000). Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J. Cell Physiol. 183, 399-410.
82. Queva, C., Hurlin, P. J., Foley, K. P. and Eisenman, R. N. (1998). Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene 16, 967-977.
83. Queva, C., McArthur, G. A., Ramos, L. S. and Eisenman, R. N. (1999). Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. Cell Growth Differ. 10, 785-796.
84. Queva, C., McArthur, G. A., Iritani, B. M. and Eisenman, R. N. (2001). Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol. Cell. Biol. 21, 703-712.
85. Rabbitts, P. H., Watson, J. V., Lamond, A., Forster, A., Stinson, M. A., Evan, G., Fischer, W., Atherton, E., Sheppard, R. and Rabbitts, T. H. (1985). Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4, 2009-2015.
86. Rosenbaum, H., Webb, E., Adams, J. M., Cory, S. and Harris, A. W. (1989). N-Myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-Myc. EMBO J. 8, 749-755.
87. Rudolph, B., Hueber, A. O. and Evan, G. I. (2001). Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene 20, 1164-1175.
88. Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A. I. and DePinho, R. A. (1995). An amino-terminal domain of mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786.
89. Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Jr, Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H. W. and DePinho, R. A. (1998). Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487.
90. Schuhmacher, M., Staege, M. S., Pajic, A., Polack, A., Weidle, U. H., Bornkamm, G. W., Eick, D. and Kohlhuber, F. (1999). Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255-1258.
91. Schwab, M. (1993). Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin. Cancer Biol. 4, 13-18.
92. Sears, R. C. (2004). The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3, 1133-1137.
93. Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M. and Massague, J. (2001). TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3, 400-408.
94. Sommer, A., Bousset, K., Kremmer, E., Austen, M. and Luscher, B. (1998). Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J. Biol. Chem. 273, 6632-6642.
95. Sommer, A., Waha, A., Tonn, J., Sorensen, N., Hurlin, P. J., Eisenman, R. N., Luscher, B. and Pietsch, T. (1999). Analysis of the Max-binding protein MNT in human medulloblastomas. Int. J. Cancer 82, 810-816.
96. Spencer, C. A. and Groudine, M. (1991). Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1-48.
97. Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Moroy, T., Bartek, J., Massague, J., Hanel, F. et al. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3, 392-399.
98. Stewart, M., Cameron, E., Campbell, M., McFarlane, R., Toth, S., Lang, K., Onions, D. and Neil, J. C. (1993). Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int. J. Cancer 53, 1023-1030.
99. Stewart, T. A., Pattengale, P. K. and Leder, P. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38, 627-637.
100. Thompson, C. B., Challoner, P. B., Neiman, P. E. and Groudine, M. (1985). Levels of c-Myc oncogene mRNA are invariant throughout the cell cycle. Nature 314, 363-366.
101. Toyo-oka, K., Hirotsune, S., Gambello, M. J., Zhou, Z. Q., Olson, L., Rosenfeld, M. G., Eisenman, R., Hurlin, P. and Wynshaw-Boris, A. (2004). Loss of the Max interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Hum. Mol. Genet. 13, 1057-1067.
102. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R. and Bishop, J. M. (2001). c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773.
103. Vastrik, I., Kaipainen, A., Penttila, T. L., Lymboussakis, A., Alitalo, R., Parvinen, M. and Alitalo, K. (1995). Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128, 1197-1208.
104. Vervoorts, J., Luscher-Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M. and Luscher, B. (2003). Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490.
105. Walker, W., Zhou, Z. Q., Ota, S., Wynshaw-Boris, A. and Hurlin, P. J. (2005). Mnt-Max to Myc-Max complex switching regulates cell cycle entry. J. Cell Biol. 169, 405-413.
106. Wanzel, M., Herold, S. and Eilers, M. (2003). Transcriptional repression by Myc. Trends Cell. Biol. 13, 146-150.
107. White, R. J. (2005). RNA polymerases I and III, growth control and cancer. Nat. Rev. Mol. Cell Biol. 6. 69-78.
108. Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J. and Larsson, L. G. (2003). Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351-360.
109. Zanet, J., Pibre, S., Jacquet, C., Ramirez, A., de Alboran, I. M. and Gandarillas, A. (2005). Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J. Cell Sci. 118, 1693-1704.
110. Zervos, A. S., Gyuris, J. and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.
111. Zhou, Z. Q. and Hurlin, P. J. (2001). The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol. 11, S10-S14.